Madziarska Katarzyna, Weyde Waclaw, Penar Jozef, Zukowska-Szczechowska Ewa, Krajewska Magdalena, Golebiowski Tomasz, Klak Renata, Zmonarski Slawomir, Kozyra Cyprian, Klinger Marian
Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
Faculty of Dentistry, Wroclaw Medical University, Wroclaw, Poland.
Postepy Hig Med Dosw (Online). 2013 Nov 20;67:1076-82. doi: 10.5604/17322693.1076915.
The aim was to identify factors carrying an ominous prognosis in a cohort of diabetic patients (pts) on a hemodialysis (HD) and peritoneal dialysis (PD) program.
We analyzed survival rates of 61 diabetic dialysis pts (35 HD/26 PD). The participants were matched in baseline characteristics, standard indicators of dialysis care and laboratory parameters. The studied group was prospectively observed up to 4 years.
21 pts (34.4%) survived the whole observation period. The annual mortality rate was 23.2%, with no difference between HD and PD. Irrespective of dialysis modality, the only factor associated with mortality in the Cox proportional hazard model was serum albumin lowering. Referring to dialysis modality, the HD survivors were characterized by lower IL-6 level, higher albumin concentration, and increased serum cholesterol values with higher cholesterol left in multivariate analysis; under PD therapy the only factor significantly associated with mortality was older age. In contrast to HD treatment, elevated cholesterol was a universal finding in PD patients, significantly above levels in HD, with a slight tendency to lower values in PD survivors.
目的是确定在接受血液透析(HD)和腹膜透析(PD)治疗的糖尿病患者队列中具有不良预后的因素。
我们分析了61例糖尿病透析患者(35例血液透析/26例腹膜透析)的生存率。参与者在基线特征、透析护理标准指标和实验室参数方面进行了匹配。对研究组进行了长达4年的前瞻性观察。
21例患者(34.4%)在整个观察期内存活。年死亡率为23.2%,血液透析和腹膜透析之间无差异。在Cox比例风险模型中,无论透析方式如何,与死亡率相关的唯一因素是血清白蛋白降低。就透析方式而言,血液透析存活者的特点是白细胞介素-6水平较低、白蛋白浓度较高,多因素分析中血清胆固醇值升高且剩余胆固醇较高;在腹膜透析治疗中,与死亡率显著相关的唯一因素是年龄较大。与血液透析治疗不同,胆固醇升高在腹膜透析患者中普遍存在,显著高于血液透析水平,腹膜透析存活者的值有轻微下降趋势。